CIK 0001299130 · Accelerated filer
PACIFIC BIOSCIENCES OF CALIFORNIA, INC.
Sign in to watch- Ticker
- PACB
- Exchange
- Nasdaq
- Industry
- Laboratory Analytical Instruments
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 161590339
- Phone
- 650-521-8000
- Business address
- 1305 O'BRIEN DRIVE, MENLO PARK, CA, 94025
- Former names
- PACIFIC BIOSCIENCES OF CALIFORNIA INC, NANOFLUIDICS INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $2,087,330
- in 2 filings, $2.1M under 10b5-1 plans
Net −$2,087,330. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 46 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2021-02-16 | Schaefer Eric Chief Accounting Officer | Grant or award · Stock Option (right to buy) | +10,100 | 10,100 | ||
| 2021-02-16 | HENRY CHRISTIAN O President & CEO | Grant or award | +15,000 | 765,000 | ||
| 2021-02-16 | HENRY CHRISTIAN O President & CEO | Grant or award · Stock Option (right to buy) | +30,000 | 30,000 | ||
| 2021-02-16 | Kim Susan G. Chief Financial Officer | Grant or award | +6,300 | 156,300 | ||
| 2021-02-16 | Kim Susan G. Chief Financial Officer | Grant or award · Stock Option (right to buy) | +12,600 | 12,600 | ||
| 2021-02-12 | Ericson William W. Director | Other disposition | −750,000 | 4,848,397 | ||
| 2021-02-12 | Ericson William W. Director | Other acquisition | +68 | 68 | ||
| 2021-02-12 | Shapiro Lucy Director | Sale | −101,666 | $50.40 | $5.1M | 0 |
| 2021-02-12 | LIVINGSTON RANDALL S Director | Option exercise | +17,500 | $10.58 | $185K | 17,500 |
| 2021-02-12 | LIVINGSTON RANDALL S Director | Option exercise | +25,000 | $1.83 | $46K | 42,500 |
| 2021-02-12 | LIVINGSTON RANDALL S Director | Option exercise | +25,000 | $2.54 | $64K | 67,500 |
| 2021-02-12 | LIVINGSTON RANDALL S Director | Sale | −67,500 | $48.07 | $3.2M | 0 |
| 2021-02-12 | LIVINGSTON RANDALL S Director | Option exercise · Stock Option (right to buy) | −17,500 | 0 | ||
| 2021-02-12 | LIVINGSTON RANDALL S Director | Option exercise · Stock Option (right to buy) | −25,000 | 0 | ||
| 2021-02-12 | LIVINGSTON RANDALL S Director | Option exercise · Stock Option (right to buy) | −25,000 | 0 | ||
| 2021-02-12 | Botstein David Director | Option exercise | +35,000 | $1.93 | $68K | 35,000 |
| 2021-02-12 | Botstein David Director | Option exercise | +25,000 | $2.54 | $64K | 60,000 |
| 2021-02-12 | Botstein David Director | Option exercise | +25,000 | $4.45 | $111K | 85,000 |
| 2021-02-12 | Botstein David Director | Option exercise | +25,000 | $5.79 | $145K | 110,000 |
| 2021-02-12 | Botstein David Director | Option exercise | +25,000 | $8.98 | $225K | 135,000 |
Page 15 of 29 · 561 trades